Cellectar BioSciences Inc. buy Oppenheimer Holdings Inc.
Start price
28.03.24
/
50%
€3.72
Target price
28.03.25
€11.09
Performance (%)
-51.34%
Price
14.08.24
€1.81
Summary
This prediction is currently active. The BUY prediction by Oppenheimer_Holdings for Cellectar BioSciences Inc. is performing very badly with a performance of -51.34%. This prediction currently runs until 28.03.25. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cellectar BioSciences Inc. | 4.023% | 4.023% |
iShares Core DAX® | 2.821% | -1.953% |
iShares Nasdaq 100 | 5.285% | -5.092% |
iShares Nikkei 225® | 3.687% | -4.221% |
iShares S&P 500 | 3.577% | -2.240% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Cellectar BioSciences Inc. diskutieren
Cellectar Biosciences, Inc. (NASDAQ: CLRB) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $12.00 price target on the stock, up previously from $11.00.
Ratings data for CLRB provided by MarketBeat